bucindolol has been researched along with Cardiac Output, Low in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Couzin, J | 1 |
| Abraham, WT; Bristow, MR; Crisman, TS; Gilbert, EM; Hattler, BG; Larrabee, P; Lowes, BD; Robertson, AD; White, M; Yoshikawa, T | 1 |
| Hjalmarson, A | 1 |
1 trial(s) available for bucindolol and Cardiac Output, Low
| Article | Year |
|---|---|
Second- and third-generation beta-blocking drugs in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiac Output, Low; Cardiomyopathy, Dilated; Carvedilol; Chronic Disease; Exercise Test; Heart Ventricles; Hemodynamics; Humans; Metoprolol; Middle Aged; Myocardial Ischemia; Oxygen Consumption; Propanolamines; Ventricular Function, Left | 1997 |
2 other study(ies) available for bucindolol and Cardiac Output, Low
| Article | Year |
|---|---|
American Association for the Advancement of Science meeting. DNA tells story of heart drug failure.
Topics: Adrenergic beta-Antagonists; Arginine; Cardiac Output, Low; Glycine; Humans; Pharmacogenetics; Polymorphism, Genetic; Propanolamines; Randomized Controlled Trials as Topic; Receptors, Adrenergic, beta-1 | 2005 |
[Beta blockers: the end of controversy].
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiac Output, Low; Carvedilol; Cause of Death; Clinical Trials as Topic; Female; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Survival Rate | 2000 |